History and development of mixed opioid agonists, partial agonists and antagonists.
about
Salvinorin A: a potent naturally occurring nonnitrogenous kappa opioid selective agonistMixed agonist-antagonist opiates and physical dependence75 years of opioid research: the exciting but vain quest for the Holy Grail30 years of dynorphins--new insights on their functions in neuropsychiatric diseasesAction of opioid agonist-antagonist drugs on the pupil and nociceptive responses in mice.Clinical efficacy of sustained-release buprenorphine with meloxicam for postoperative analgesia in beagle dogs undergoing ovariohysterectomy.Tolerance to the mydriatic effect of buprenorphine, butorphanol, nalbuphine, and cyclorphan, and cross-tolerance to morphine in mice.Opioid agonist and antagonist behavioural effects of buprenorphineThe Emerging Role of Spinal Dynorphin in Chronic Pain: A Therapeutic PerspectiveA systematic review of combination step III opioid therapy in cancer pain: an EPCRC opioid guideline project.A physiologically based pharmacokinetic modelling approach to predict buprenorphine pharmacokinetics following intravenous and sublingual administration.New Technologies for Elucidating Opioid Receptor Function.Addressing the barriers related with opioid therapy for management of chronic pain in India.Intramuscularly administered ciramadol for management of postoperative pain: a comparative study.The effect of buprenorphine and oxycodone on the intracholedochal passage pressure.Animal and molecular pharmacology of mixed agonist-antagonist analgesic drugs.The contribution of intrinsic activity to the action of opioids in vitro.Novel 18F-Labeled κ-Opioid Receptor Antagonist as PET Radiotracer: Synthesis and In Vivo Evaluation of 18F-LY2459989 in Nonhuman Primates.Cross-tolerance and enhanced sensitivity to the response rate-decreasing effects of opioids with varying degrees of efficacy at the mu receptor.
P2860
Q24535736-5BA650B9-F254-4320-AE2A-2B8D2345F7B9Q24547874-1DB2351F-CDA7-4836-AD84-FE4DE67FE91EQ24670315-08D1EFFD-9B63-40D7-B468-104CAABFFDE4Q30481450-0B4FDA61-9929-4360-A494-E67B63B1F23FQ31100970-EE548D75-129B-42FA-9A79-A458986CF2CAQ34274329-9BBEFA43-8CDB-454E-A8B9-EB0EA66DF0ABQ34659970-F1D91833-9890-4234-B52E-A0A993C6519BQ36097592-5F0D32E2-851C-4803-865E-D2C215047408Q36992406-52F47689-040C-44F7-9DAB-870C59A1FF7FQ37895006-F3FDA7F9-577A-412F-A4C6-792AA4C677A7Q38661092-CB5E1A17-81BC-43CA-88D1-4572E3822681Q38718788-99B89B71-1281-4FA9-BAA7-64592146C32CQ39430089-1810DBE2-771C-42D3-80EF-A7D6F286DA84Q39559589-B8CD1FC5-E588-4C21-80BC-D28B447DBC49Q39568050-A3A27369-08A0-4B5A-B41D-8D9A81CE50F9Q40243421-ADA268BB-7AAA-43A6-B1C6-725D5875226DQ41965104-2C4EFE34-81AB-4C02-B665-1AA374056D1DQ44347602-BFC4CA29-00AE-482C-994B-CE54CC502407Q52239231-845AAF5C-9EA4-4218-978C-64286893886E
P2860
History and development of mixed opioid agonists, partial agonists and antagonists.
description
1979 nî lūn-bûn
@nan
1979年の論文
@ja
1979年学术文章
@wuu
1979年学术文章
@zh-cn
1979年学术文章
@zh-hans
1979年学术文章
@zh-my
1979年学术文章
@zh-sg
1979年學術文章
@yue
1979年學術文章
@zh
1979年學術文章
@zh-hant
name
History and development of mixed opioid agonists, partial agonists and antagonists.
@en
type
label
History and development of mixed opioid agonists, partial agonists and antagonists.
@en
prefLabel
History and development of mixed opioid agonists, partial agonists and antagonists.
@en
P2860
P1476
History and development of mixed opioid agonists, partial agonists and antagonists.
@en
P2093
P2860
P304
P356
10.1111/J.1365-2125.1979.TB04700.X
P407
P478
P577
1979-01-01T00:00:00Z